Recro Pharma (NASDAQ:REPH) Stock Jumps 30% Last Week: Here is Why

August 14, 2021

Contract development and manufacturing organization solving complex formulation and manufacturing challenges, Recro Pharma (NASDAQ:REPH) announced on August 13, 2021 acquisition of San Diego-based CDMO, IRISYS, possessing capabilities for expanding Recro’s requirements. The acquisition cost about $50 million through a mix of cash, shares of Recro as well as seller promissory notes. The firm is transforming into a complete CDMO with operations on both the West and East Coast of the…